227 related articles for article (PubMed ID: 30334178)
1. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
Chakedis J; Beal EW; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Marincola-Smith P; Cho C; Beems M; Pawlik TM; Maithel SK; Schmidt CR; Dillhoff M
J Gastrointest Surg; 2019 Jan; 23(1):122-134. PubMed ID: 30334178
[TBL] [Abstract][Full Text] [Related]
2. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.
Kimbrough CW; Beal EW; Dillhoff ME; Schmidt CR; Pawlik TM; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Crown A; Abbott DE; Fisher AV; Fields RC; Krasnick BA; Idrees K; Marincola-Smith P; Cho CS; Beems M; Maithel SK; Cloyd JM
Surgery; 2019 Mar; 165(3):657-663. PubMed ID: 30377003
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
4. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
5. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs).
Scott AT; Breheny PJ; Keck KJ; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Surgery; 2019 Jan; 165(1):166-175. PubMed ID: 30343949
[TBL] [Abstract][Full Text] [Related]
6. Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
Korda D; Doros A; Piros L; Gerlei Z; Haboub-Sandil A; Mándli T; Fazakas J; Deák ÁP; Máthé Z
Transplant Proc; 2019 May; 51(4):1251-1253. PubMed ID: 31101208
[TBL] [Abstract][Full Text] [Related]
7. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
8. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?
Maxwell JE; Sherman SK; O'Dorisio TM; Bellizzi AM; Howe JR
Surgery; 2016 Jan; 159(1):320-33. PubMed ID: 26454679
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
Spolverato G; Bagante F; Aldrighetti L; Poultsides G; Bauer TW; Field RC; Marques HP; Weiss M; Maithel SK; Pawlik TM
J Gastrointest Surg; 2017 Dec; 21(12):2039-2047. PubMed ID: 28744737
[TBL] [Abstract][Full Text] [Related]
10. Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy.
Maekawa A; Kudo A; Kishino M; Murase Y; Watanabe S; Ishikawa Y; Ueda H; Akahoshi K; Ogawa K; Ono H; Tanaka S; Kinowaki Y; Tanabe M
J Cancer Res Clin Oncol; 2022 Mar; 148(3):697-706. PubMed ID: 33904982
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of neuroendocrine tumors.
Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
[TBL] [Abstract][Full Text] [Related]
12. Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors.
Du S; Ni J; Weng L; Ma F; Li S; Wang W; Sang X; Lu X; Zhong S; Mao Y
Medicine (Baltimore); 2015 Aug; 94(34):e1429. PubMed ID: 26313798
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 Labeling Index Variability Between Surgically Resected Primary and Metastatic Hepatic Lesions of Gastroenteropancreatic Neuroendocrine Neoplasms.
Furukawa T; Ozaka M; Takamatsu M; Takazawa Y; Inamura K; Inoue Y; Mie T; Takeda T; Kanata R; Kasuga A; Matsuyama M; Sasaki T; Takahashi Y; Sasahira N
Int J Surg Pathol; 2021 Aug; 29(5):475-481. PubMed ID: 33543658
[No Abstract] [Full Text] [Related]
14. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
[TBL] [Abstract][Full Text] [Related]
15. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery.
Jaeck D; Oussoultzoglou E; Bachellier P; Lemarque P; Weber JC; Nakano H; Wolf P
World J Surg; 2001 Jun; 25(6):689-92. PubMed ID: 11376398
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.
Sham JG; Ejaz A; Gage MM; Bagante F; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM; He J
J Gastrointest Surg; 2019 Mar; 23(3):484-491. PubMed ID: 29980977
[TBL] [Abstract][Full Text] [Related]
17. Clinical analysis of gastroenteropancreatic neuroendocrine tumor with liver metastasis, compared with primary hepatic neuroendocrine tumor.
Shen YH; Chen S; Zhang WT; Ji Y; Yu L; Sun HC; Qiu SJ; Ren N; Zhou J
J Cancer Res Ther; 2014 Dec; 10 Suppl():276-80. PubMed ID: 25693935
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases.
Croome KP; Burns JM; G Que F; Nagorney DM
Ann Surg Oncol; 2016 Oct; 23(11):3693-3698. PubMed ID: 27188296
[TBL] [Abstract][Full Text] [Related]
19. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
[TBL] [Abstract][Full Text] [Related]
20. Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.
Qiu MJ; Chen YB; Bi NR; Yang SL; He XX; Xiong ZF
Dis Markers; 2018; 2018():9191639. PubMed ID: 30416612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
